Robert M. Davis has been growing his shareholdings in Merck & Co., Inc. significantly over the years. As of early 2024, his common stock in the company is valued at over $40 million, demonstrating a substantial personal investment aligned with...

Robert M. Davis has been growing his shareholdings in Merck & Co., Inc. significantly over the years. As of early 2024, his common stock in the company is valued at over $40 million, demonstrating a substantial personal investment aligned with the company's success. Additionally, he holds stock options worth over $11 million, which can be a major source of income if the company's stock performs well. This indicates his deep confidence in Merck and its future. His holdings have expanded since he took on key roles at the company, particularly after being promoted to CEO. His wealth tied to Merck’s stock shows his direct stake in the company's performance, making it clear that he is committed to delivering strong results for shareholders.